Rheo-Erythrocrine Dysfunction as a Biomarker for RIC Treatment in Acute Ischemic Stroke
Clinical trial NCT04266639 · COMPLETED
Trial details
- NCT number
- NCT04266639
- Sponsor
- Grethe Andersen
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2021-07-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.